The effects of antidepressant treatment in prenatally stressed rats support the glutamatergic hypothesis of stress-related disorders

Journal of Neuroscience

Volumn 34, Issue 6, 2014, Pages 2015-2024

  Marrocco, Jordan ^a   Reynaert, Marie Line ^b,f   Gatta, Eleonora ^b,f   Gabriel, Cecilia ^c   Mocaër, Elisabeth ^c   Di Prisco, Silvia ^d   Merega, Elisa ^d   Pittaluga, Anna ^d   Nicoletti, Ferdinando ^e,f   Maccari, Stefania ^b,f   Morley Fletcher, Sara ^b,f   Mairesse, Jérôme ^b,f  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^d UNIVERSITY OF GENOA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f International Associated Laboratory Prenatal Stress and Neurodegenerative Diseases   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AGOMELATINE; FLUOXETINE; GLUTAMIC ACID; MUNC18 PROTEIN; RAB PROTEIN; SNARE PROTEIN; SYNAPSIN I; SYNAPSIN II; SYNAPTOBREVIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; EARLY LIFE STRESS; FEMALE; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILIZATION STRESS; LIGHT-DARK TEST; MALE; MEMBRANE DEPOLARIZATION; MEMORY; MENTAL PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPTIC TRANSMISSION; WESTERN BLOTTING;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSION; FEMALE; GLUTAMIC ACID; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84893458661     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4131-13.2014     Document Type: Article

References (63)

1. Baldwin DS, Lopes AT (2009) Agomelatine improves symptoms of generalised anxiety disorder. Evid Based Ment Health 2: 54. CrossRef Medline
2. Banasr M, Soumier A, Hery M, Mocaër E, Daszuta A (2006) Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 59: 1087-1096. CrossRef Medline
3. Bannerman DM, Rawlins JN, McHugh SB, Deacon RM, Yee BK, Bast T, Zhang WN, Pothuizen HH, Feldon J (2004) Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 28: 273-283. CrossRef Medline
4. Becker G, Kowall M (1977) Crucial role of the postnatal maternal environment in the expression of prenatal stress effects in the male rats. J Comp Physiol Psychol 91: 1432-1446. CrossRef Medline
5. Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, Schatzberg AF, Myers RM, Akil H, Watson SJ (2011) Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 16: 634-646. CrossRef Medline
6. Blazevic S, Colic L, Culig L, Hranilovic D (2012) Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations. Behav Brain Res 230: 175-181. CrossRef Medline
7. Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L, Raiteri M, Racagni G, Popoli M (2005) Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 25: 3270-3279. CrossRef Medline
8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254. Medline
9. Chapman RH, Stern JM (1979) Failure of severe maternal stress or ACTH during pregnancy to affect emotionality of male rat offspring: implications of litter effects for prenatal studies. Dev Psychobiol 12: 255-267. CrossRef Medline
10. Chen G, Henter ID, Manji HK (2010) Presynaptic glutamatergic dysfunction in bipolar disorder. Biol Psychiatry 67: 1007-1009. CrossRef Medline
11. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr, Akil H, Watson SJ, Jones EG (2005) Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 102: 15653-15658. CrossRef Medline
12. Dantzer R, Bluthe RM, Koob GF, Le Moal M (1987) Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berl) 91: 363-368. Medline
13. Darnaudéry M, Maccari S (2008) Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Res Rev 57: 571-585. CrossRef Medline
14. de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ (2010) Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 9: 628-642. CrossRef Medline
15. Dugovic C, Maccari S, Weibel L, Turek FW, Van Reeth O (1999) High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 19: 8656-8664. Medline
16. Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA (1986) A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 372: 115-129. CrossRef Medline
17. Engin E, Treit D (2007) The role of hippocampus in anxiety: intracerebral infusion studies. Behav Pharmacol 18: 365-374. CrossRef Medline
18. Fanselow MS, Dong HW (2010) Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65: 7-19. CrossRef Medline
19. Garcia-Garcia AL, Elizalde N, Matrov D, Harro J, Wojcik SM, Venzala E, Ramírez MJ, Del Rio J, Tordera RM (2009) Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol Psychiatry 66: 275-282. CrossRef Medline
20. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder (2009) Brain Res Rev 61: 105-123. CrossRef
21. Holden C. Psychiatric drugs (2003) Excited by glutamate. Science 300: 1866-1868. CrossRef Medline
22. Isingrini E, Camus V, Le Guisquet AM, Pingaud M, Devers S, Belzung C (2010) Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice. PLoS One 4: e10404. CrossRef Medline
23. Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ (2010) Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry 71: 109-120. CrossRef Medline
24. Krishnan V, Nestler EJ (2010) Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167: 1305-1320. CrossRef Medline
25. Landgraf R, Gerstberger R, Montkowski A, Probst JC, Wotjak CT, Holsboer F, Engelmann M (1995) V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J Neurosci 15: 4250-4258. Medline
26. Levitan MN, Papelbaum M, Nardi AE (2012) A review of preliminary observations on agomelatine in the treatment of anxiety disorders. Exp Clin Psychopharmacol 20: 504-509. CrossRef Medline
27. Loiseau F, Le Bihan C, Hamon M, Thiébot MH (2006) Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam. Eur Neuropsychopharmacol 16: 417-428. CrossRef Medline
28. Maccari S, Piazza PV, Kabbaj M, Barbazanges A, Simon H, Le Moal M (1995) Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J Neurosci 15: 110-116. Medline
29. Maeng S, Zarate CA Jr (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9: 467-474. CrossRef Medline
30. Mairesse J, Silletti V, Laloux C, Zuena AR, Giovine A, Consolazione M, van Camp G, Malagodi M, Gaetani S, Cianci S, Catalani A, Mennuni G, Mazzetta A, van Reeth O, Gabriel C, Mocaër E, Nicoletti F, Morley-Fletcher S, Maccari S (2013) Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/ wake cycle induced by prenatal restraint stress in adult rats. Int J Neuropsychopharmacol 16: 323-338. CrossRef Medline
31. Marrocco J, Mairesse J, Ngomba RT, Silletti V, Van Camp G, Bouwalerh H, Summa M, Pittaluga A, Nicoletti F, Maccari S, Morley-Fletcher S (2012) Anxiety-like behavior of prenatally stressed rats is associated with a selective reduction of glutamate release in the ventral hippocampus. J Neurosci 32: 17143-17154. CrossRef Medline
32. McCarthy DJ, Alexander R, Smith MA, Pathak S, Kanes S, Lee CM, Sanacora G (2012) Glutamate-based depression GBD. Med Hypotheses 78: 675-681. CrossRef Medline
33. Milanese M, Tardito D, Musazzi L, Treccani G, Mallei A, Bonifacino T, Gabriel C, Mocaer E, Racagni G, Popoli M, Bonanno G (2013) Chronic treatment with agomelatine or venlafaxine reduces depolarizationevoked glutamate release from hippocampal synaptosomes. BMCNeurosci 14: 75. CrossRef Medline
34. Millan MJ, Brocco M, Gobert A, Dekeyne A (2005) Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl) 177: 448-458. CrossRef Medline
35. Morley-Fletcher S, Darnaudery M, Koehl M, Casolini P, Van Reeth O, Maccari S (2003) Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Res 989: 246-251. CrossRef Medline
36. Morley-Fletcher S, Mairesse J, Soumier A, Banasr M, Fagioli F, Gabriel C, Mocaer E, Daszuta A, McEwen B, Nicoletti F, Maccari S (2011) Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats. Psychopharmacology (Berl) 217: 301-313. CrossRef Medline
37. Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, Barbiero VS, Bonifacino T, Mallei A, Baldelli P, Racagni G, Raiteri M, Benfenati F, Bonanno G, Popoli M (2010) Acute stress increases depolarizationevoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS One 5: e8566. CrossRef Medline
38. Musazzi L, Treccani G, Mallei A, Popoli M (2013) The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol Psychiatry 73: 1180-1188. CrossRef Medline
39. Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, Battaglia G, Mathé AA, Pittaluga A, Lionetto L, Simmaco M, Nicoletti F (2013) L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci U S A 110: 4804-4809. CrossRef Medline
40. Nibuya M, Nestler EJ, Duman RS (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16: 2365-2372. Medline
41. Ongür D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, Renshaw PF (2008) Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry 64: 718-726. CrossRef Medline
42. Papp M, Gruca P, Boyer PA, Mocaër E (2003) Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28: 694-703. CrossRef Medline
43. Papp M, Litwa E, Gruca P, Mocaër E (2006) Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behav Pharmacol 17: 9-18. Medline
44. Popoli M, Yan Z, McEwen BS, Sanacora G (2011) The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13: 22-37. CrossRef Medline
45. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391. CrossRef Medline
46. Pothion S, Bizot JC, Trovero F, Belzung C (2004) Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 155: 135-146. CrossRef Medline
47. Raiteri L, Raiteri M (2000) Synaptosomes still viable after 25 years of superfusion. Neurochem Res 25: 1265-1274. CrossRef Medline
48. Raiteri M, Angelini F, Levi G (1974) A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 25: 411-414. CrossRef Medline
49. Reagan LP, Reznikov LR, Evans AN, Gabriel C, Mocaër E, Fadel JR (2012) The antidepressant agomelatine inhibits stress-mediated changes in amino acid efflux in the rat hippocampus and amygdala. Brain Res 1466: 91-98. CrossRef Medline
50. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809. CrossRef Medline
51. Sommi RW, Crismon ML, Bowden CL (1987) Fluoxetine: a serotoninspecific, second-generation antidepressant. Pharmacotherapy 7: 1-15. CrossRef Medline
52. Soumier A, Banasr M, Lortet S, Masmejean F, Bernard N, Kerkerian-Le-Goff L, Gabriel C, Millan MJ, Mocaer E, Daszuta A (2009) Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology 34: 2390-2403. CrossRef Medline
53. Stein DJ, Ahokas AA, de Bodinat C (2008) Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebocontrolled study. J Clin Psychopharmacol 28: 561-566. CrossRef Medline
54. Stein DJ, Ahokas A, Albarran C, Olivier V, Allgulander C (2012) Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study. J Clin Psychiatry 73: 1002-1008. CrossRef Medline
55. Stokes PE, Holtz A (1997) Fluoxetine tenth anniversary update: the progress continues. Clin Ther 19: 1135-1250. CrossRef Medline
56. Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G, Hen R, Belzung C (2008) Drug-dependent requirement of hippocampal neuro-genesis in a model of depression and of antidepressant reversal. Biol Psychiatry 64: 293-301. CrossRef Medline
57. Tardito D, Milanese M, Bonifacino T, Musazzi L, Grilli M, Mallei A, Mocaer E, Gabriel-Gracia C, Racagni G, Popoli M, Bonanno G (2010) Blockade of stressinduced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptordependent pathways. BMCNeurosci 11: 68. CrossRef Medline
58. Tordera RM, Totterdell S, Wojcik SM, Brose N, Elizalde N, Lasheras B, Del Rio J (2007) Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci 25: 281-290. CrossRef Medline
59. Tuma J, Strubbe JH, Mocaër E, Koolhaas JM (2005) Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN. Eur Neuropsychopharmacol 15: 545-555. CrossRef Medline
60. Van Reeth O, Olivares E, Zhang Y, Zee PC, Mocaer E, Defrance R, Turek FW (1997) Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters. Brain Res 762: 185-194. CrossRef Medline
61. Vialou V, Feng J, Robison AJ, Nestler EJ (2013) Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Toxicol 53: 59-87. CrossRef Medline
62. Yalcin I, Aksu F, Belzung C (2005) Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. Eur J Pharmacol 514: 165-174. CrossRef Medline
63. Zuena AR, Mairesse J, Casolini P, Cinque C, Alemà GS, Morley-Fletcher S, Chiodi V, Spagnoli LG, Gradini R, Catalani A, Nicoletti F, Maccari S (2008) Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats. PLoS One 3: e2170. CrossRef Medline